Issue link: http://osercommunicationsgroup.uberflip.com/i/499803
C h a i n D r u g s t o r e D a i l y S a t u r d a y, A p r i l 2 5 , 2 0 1 5 8 GROWING PHARMACEUTICAL OFFERS HIGH-QUALITY GENERICS As the largest generic pharmaceutical company in India and the fifth largest in the world, Sun Pharmaceutical Industries, LLC (Sun Pharma) offers a range of high-quality generics across dosage forms, with strong portfolios in controlled substances and anticancers. Since Sun Pharma's recent acquisitions of Ranbaxy and URL Pharma, its product basket has strengthened. Initiating a pres- ence in the dermatology device market is now possible due to Sun Pharma's acqui- sition of DUSA and its patented busi- nesses, Levulan ® and BLU-U ® blue- light device. Sun Pharma believes the $70 billion U.S. generic market offers a tremendous opportunity to bring patients high-quality pharmaceuticals, made to exacting stan- dards of FDA-approved plants in both the U.S. and India. Starting with simple dosage forms, tablets and capsules, its range has now grown to encompass dif- ferentiated products such as nanoparti- cle-based injections for targeted drug delivery, lyophilized injections, auto- injections and controlled release prod- ucts. Being one of the few generics com- panies that have manufacturing plants in both the U.S. and India, Sun Pharma now stands with six dosage form plants in the U.S., in addition to three plants in India that are USFDA approved. Its Cranbury, N.J. plant is designed to make controlled substance formulations and for API, Sun Pharma has three approved plants in India, in addition to a plant each in the U.S. (Chattem Chemicals) and Hungary. This exceptional growth comes from a start of two FDA-approved plants, one Indian and one U.S. mainland, that were formed in 1997. These plants are designed, built, and ran to stringent FDA require- ments. Sun Pharma's ability to develop processes and make in-house API for complex products such as peptides, con- trolled substances and hormones ensure that not only is the best quality API used, but are also among the most efficient pro- ducers. Sun Pharma has over 375 ANDAs approved with over 90 ANDAs awaiting approval, with filings for complex prod- ucts such as nasal sprays, depot injec- tions and modified-release products. Being one of the strongest pipelines among Indian com- panies, each year it files approximately 20 ANDAs to replenish that pipeline. Across four world-class research centers, over 800 sci- entists work on process and product development so that Sun Pharma is able to continu- ally file for ANDA and API, moving up the scale in terms of complexity. A strong patent team works with its scientists to examine possibilities for non-infringing processes or science-based patent chal- lenges. With clear plans for growth, Sun Pharma is keen to grow its U.S. presence and bring the customer high-quality generics that can be trusted. For more information, stop by booth #300. CROSSMARK DRUG & VALUE: DELIVERING GROWTH SOLUTIONS IN A CHANGING ENVIRONMENT By: Steve Valentino "The only constant in retailing is change." This phrase was common in our industry 25 years ago and it still rings true today. Our industry is working through a new cycle of change driven by healthcare trends that are becoming a driving force in the U.S., the concept of convenience being redefined while at the same time labor costs are rising, big data complexity and the need for clear insights that translate into solutions, defining Omni Channel and how online shopping connects to brick and mortar retail stores and the question of how we can take tools available to make shopping experimental and fun again. These trends, and more, present an interesting challenge to figure out how we can all deliver more value and be profitable at the same time. Significant trends in healthcare are creating a rising tide. We are moving in the U.S. from a treatment culture to a wellness culture. The wave of Baby Boomers with increased health needs is upon us, as ten thousand people in the U.S. turn 65 everyday and will do so every day for the next 15-plus years, according to the U.S. census. The Affordable Care Act, insurance man- dates, consumerism and a physician shortage will all drive a need for services and in-store support for retailers ready to provide them along with suppliers ready to engage. Health-connected services and capabilities focused in health, beauty and overall convenience will drive traffic and build baskets. Retailer sophistication, tech- nology and Big Data demands have raised standards across the value chain. Loyalty, Digital and Dot- Com are driving new retailer strate- gies and decision-making with a focus on localization and personifi- cation. With insights being today's currency, the ability to effectively and effi- ciently glean insights and drive a plan through to activation and measurement is what truly creates differentiation. Clients hire CROSSMARK to help them develop a smarter way to foster growth for their business. CROSSMARK develops strategies across the drug and value channels to capitalize on these trends and drive differentiation for clients, as well as unique and thoughtful activation for each retailer. At the heart of the company are end-to-end capabilities from "thought to bought," with an inno- vative business planning and go-to-mar- ket process, CROSSVIEW, that delivers better insights, better planning and better execution. CROSSMARK has world- class capabilities in analytics and insights, shopper and experiential marketing and merchandising and execution, delivering clients new solutions to solve for the chal- lenges in today's dynamic, ever- evolving environment. As you reflect on your busi- ness, do you have a plan to position your product as a proactive health solu- tion fro Drug shoppers and a smart healthcare value option for dollar shop- pers, all while staying true to your brands? Do you have data and loyalty capabilities to bring meaningful insights to retailers? Is there leverage to increase traffic to pharmacies and convert shop- pers to choose your items? Can you be the vendor who helps retailers accom- plish their goals in this space? CROSSMARK Drug & Value can help you develop winning strategies and activate plans through tools and execu- tion capabilities that master challenges and engineer growth opportunities. For more information visit www .crossmark.com. SUCCESSFUL STRATEGIES TO SWEETEN SEASONAL SALES With seasonal candy representing 50 per- cent of drug channel confectionery sales, staying on-trend will make two holidays brighter for retailers. Celebrate each sea- son by leveraging these key consumer insights: Easter has become a chocolate lover's tradition with more than 60 per- cent of consumers celebrating Easter and 96 percent of Easter baskets including chocolate of some kind inside. M&M'S ® Brand is the number one brand for Easter baskets, candy bowls and egg hunts. Consumers will delight in the 2015 line- up, including M&M'S Brand Cane with bunny ears, DOVE ® Chocolate Solid Bunnies and MINIS MIX™ Chocolates in a stand up pouch. Retailers will attract impulse sales with the Mixed Singles Shapes Tower, which is double-sided and loaded with top-performing items. With Halloween and candy being almost synonymous with one another, understanding how to handle this season- al product begins with utilizing variety packs, as they carve out 83 percent of surveyed consumers who find that vari- ety bags make Halloween shopping easi- er. In 2014, Mars had five of the top 10 selling chocolate items, while continuing to invest in its variety bag portfolio. In addition to variety packs, Mars satisfies trick-or-treaters with FUN SIZE ® favorites such as SNICKERS ® , TWIX ® , and M&M'S Brands. Attention-grabbing Halloween pack- aging will generate excitement on-shelf. Shoppers will howl with delight when they see their favorites renamed, as SNICKERS Xtreme becomes SNICK- ERS Xscream and 3 MUSKETEERS Bar transforms to 3 MuskeFEARS Bar with red nougat. M&M'S Brand is the most-pur- chased chocolate for Christmas baking, gifting, decorating, stuffing stockings and filling extra bowls and according to some surveys, 90 percent of consumers participate in Christmas with about half baking cookies and sweets and three-quarters of bakers using choco- late candies. New in 2015: SNICKERS ® Brand Baking Bites for the Holidays add a delightfully familiar flavor to holiday recipes. Shoppers will continue to buy seasonal favorites, like DOVE PROMISES Peppermint Bark, as well as new twists to their favorite brands, like M&M'S Brand White Peppermint Candies for the Holidays and M&M'S Brand Mint Chocolate Candies Cane. Valentine's Day is known as the sea- son's go-to for chocolate consumption, with Valentine's Day chocolate pur- chasers spending an average of $23 on chocolate gifts for spouses and partners, children, grandchildren, friends and neighbors. M&M'S Brand is a top Valentine's Day treat, with shoppers showing their true love for M&M'S Chocolate Candies with purchases of colorful candy bowls and other gifts from the heart. Extra holiday tips that add to suc- cessful strategies begin with spotlighting the season with secondary displays in high traffic areas. Mars makes it easy with eye-catch- ing displays, from shippers with the new Mixed Shapes & Singles Tower, which retailers can stand, hang or mount to capture impulse buys. Amp up seasonal excitement with vibrant seasonal packaging from Mars that adds excitement to the seasonal aisle, attracts attention to stand out on-shelf, and is an important cue to connect with the shopper. Take advantage of the fact that shop- pers gobble up seasonal shapes, so be sure to stock up on the most popular, including TWIX Ghosts and Santas, SNICKERS ® Pumpkins and Trees, and MILKYWAY Simply Caramel Snowmen. From traditional holiday favorites to innovative new flavors, Mars has the drug channel's seasonal success in the bag! Visit Mars at booth #226. For more infor- mation, go to www.mars.com or call 800.631.7630.